top of page
World Council of Churches (WCC)

28. Equip, mobilize, and support faith leaders, FBOs, people in places of worship, and the wider community to create demand for testing of infants and children.

29. Combat stigma and discrimination among faith leaders and within communities of faith.

30. Further collaborate and coordinate community mobilization, education and outreach to find otherwise hard-to-reach children, adolescents, youth and adults for age appropriate prevention education, testing and linkage to treatment and health and social support services and integrate into the national system.

31. Ensure FBO participation in local and national diagnostic product/supplies forecasting.

32. Support and participate in national efforts to improve the use and impact of pediatric diagnostics and develop national strategies to optimize the use of new technologies and interventions.

33. Work to implement new HIVST modalities (such as oral fluid testing) in communities and homes, where national polices and regulations allow for lay implementation with children.



28. Feb. 2024: From 2020-2022, WCC lead 11 events/activities to enable Access to HIV prevention, testing & treatment, directly benefiting 546 people creating demand for early diagnosis of children living with and affected by HIV.

28. June 2024: Ongoing

29. 2019: Through the ‘Leading by Example: Religious Leaders and HIV Testing Campaign’, the WCC-EAA engaged religious leaders from different faith traditions to promote testing and linkage to services in faith communities, including by providing awareness on HIV and by creating stigma and discrimination free communities. This initiative promoted a strong linkage between faith communities and health-care facilities with the purpose of ensuring that more children are tested and retained for treatment. WCC-EAA has mobilized and supported faith leaders (Paediatric HIV Champions) and FBOs in advocacy on paediatric HIV.

29. Feb 2024In 2023 WCC conducted 2 Framework for Dialogue (Uganda and Nigeria) processes aimed to discuss HIV stigma and discrimination including against children living with HIV and affected. With relevant stakeholders, developed an Analysis on the impact of HIV stigma in the uptake of services among women, children and adolescents with focus in Uganda and Nigeria

29. June 2024: Ongoing

30. Feb 2024In 2023 WCC coordinated local joint action plans to respond to the impacts of HIV stigma in the uptake of services among women, children and adolescents in Uganda and Nigeria. In 2023 WCC supported the Christian Council of Nigeria (CCN) to adopt commitments for the wellbeing of adolescents

30. June 2024: Ongoing

32. June 2024: Delayed, it will be included in recommendations of the WCC Analysis of HIV stigma impact in the uptake of services among women, children and adolescents in Uganda and Nigeria.


52. Ensure FBO participation in local and national forecasting of optimal paediatric drug formulations.

53. Collaborate with GAP-f partners to develop, test, and disseminate training tools for treatment initiation with LPV/r and other optimal pediatric formulations.

54. Support and increase family treatment initiation and retention for children, adolescents, and families by:

  • Increasing identification and provision of same-day/same-appointment mother/infant pair treatment through FBO clinics;

  • Promoting male/father engagement in EMTCT programmes; and

  • Increasing stigma reduction interventions through mobilized faith leaders and faith communities

  • Providing social work interventions to assist fathers to support treatment and adherence of their partners and children living with HIV.

55. Foster and more actively participate in coordinated and collaborative advocacy to:

  • Increase funding for research & development, introduction and scale-up of priority pediatric drugs and formulations;

  • Accelerate regulatory processes for rapid adoption and uptake of optimal paediatric drugs and formulations; and

  • Ensure sustainable access to optimal testing and treatment for infants and children.




Action 10: Promote the revision of national procurement plans to align with WHO recommended regimens and the Optimal Formulary, and support the provision of reliable forecasts and the consolidation of orders.

Action 22: Support the early adoption of priority formulations and diagnostics and take steps to facilitate their wider roll-out, including by developing introductory guidance, materials, and other tools for health facilities.

Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.

Action 28. Raising awareness in global fora about the unmet diagnostic and treatment needs of children with HIV.

Action 29. Promote uptake by mobilizing their networks of hospitals and community structures to distribute paediatric medicines in hard to reach places and in situations of conflict and crisis.

Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.

10. 22. 29. 34. June 2024Delayed, it will be included in recommendations of the WCC Analysis of HIV stigma impact in the uptake of services among women, children and adolescents in Uganda and Nigeria.

27. 28. June 2024: Ongoing



bottom of page